<p>Doximity（纽约证券交易所代码：DOCS - 获取免费报告）在周四发布给投资者的报告中，摩根大通将其目标价格从 33.00 美元下调至 28.00 美元。该公司目前对该股票的评级为 “中性”。摩根大通的目标价格暗示该公司股价有 60.38% 的潜在上涨空间。</p>
<ul>
<li>Doximity 是医疗社区的 Facebook 和 LinkedIn</li>
</ul>
<p>其他几家券商也最近对 DOCS 发表了评论。罗伯特·W·贝尔德在周四的报告中重申了 “中性” 评级，并将 Doximity 的目标价格设定为 18.00 美元（从 40.00 美元下调）。BMO 资本市场将 Doximity 的目标价格从 25.00 美元下调至 20.00 美元，并在周四的报告中对该公司给予 “市场表现” 评级。美国银行将 Doximity 的目标价格从 56.00 美元下调至 47.00 美元，并在 4 月 16 日的研究报告中对该公司给予 “买入” 评级。Needham &amp; Company LLC 将 Doximity 的目标价格从 55.00 美元下调至 27.00 美元，并在周四的研究报告中对该公司给予 “买入” 评级。最后，杰弗瑞金融集团将 Doximity 的评级从 “买入” 下调至 “持有”，并为该公司设定了 19.00 美元的目标价格。两位分析师对该股票给予了强烈买入评级，八位给予了买入评级，十三位对该公司的股票给予了持有评级。根据 MarketBeat.com 的数据，该股票目前的平均评级为 “适度买入”，共识目标价格为 31.48 美元。</p>
<p><strong>查看我们对 Doximity 的最新股票分析</strong></p>
<h2>Doximity 股票表现</h2>
<ul>
<li>Doximity 是一个被忽视的医疗生态系统 AI 投资</li>
</ul>
<p>周四，DOCS 股票下跌 5.93 美元，跌至 17.46 美元。该公司共交易了 17,685,978 股股票，而其平均交易量为 3,604,347 股。Doximity 的 1 年最低价为 17.15 美元，1 年最高价为 76.51 美元。该公司的市值为 32.2 亿美元，市盈率为 14.64，市盈增长比率为 1.88，贝塔值为 1.36。该股票的 50 日移动平均线为 24.27 美元。</p>
<p>Doximity 宣布其董事会于 2 月 5 日启动了一项股票回购计划，允许公司回购 5 亿美元的股票。该回购授权允许公司通过公开市场购买最多 8% 的股份。股票回购计划通常表明公司的管理层认为其股票被低估。</p>
<h2>内部活动</h2>
<ul>
<li>Doximity 股票是一个有趣的医疗投资</li>
</ul>
<p>在其他 Doximity 新闻中，内部人士 Siddharth Sitaram 在 5 月 11 日的交易中出售了 2,309 股股票，平均售价为 25.77 美元，总价值为 59,502.93 美元。出售完成后，该内部人士持有 89,396 股公司股票，价值约为 2,303,734.92 美元。这代表其持股减少了 2.52%。该交易在向证券交易委员会的备案中披露，相关信息可通过此链接获取。该交易是在预先安排的 10b5-1 交易计划下执行的。出售是为了覆盖与股权奖励归属相关的税收扣缴义务。此外，董事 Kira Scherer Wampler 在 5 月 7 日的交易中出售了 9,000 股股票，平均售价为 26.06 美元，总交易额为 234,540.00 美元。出售完成后，该董事持有 19,839 股公司股票，价值约为 517,004.34 美元。该交易使其持股减少了 31.21%。该出售的 SEC 备案提供了更多信息。该交易是在预先安排的 10b5-1 交易计划下执行的。在过去三个月中，内部人士出售了价值 456,061 美元的 18,055 股公司股票。公司内部人士持有公司股票的 31.30%。</p>
<h2>机构投资者对 Doximity 的看法</h2>
<p>一些对冲基金和其他机构投资者最近增加或减少了对该股票的持股。先锋集团在第四季度将其在 Doximity 的持股增加了 4.1%。先锋集团目前持有 13,285,485 股公司股票，价值 588,281,000 美元，在上个季度又增持了 518,916 股。Aubrey Capital Management Ltd 在第三季度购买了 Doximity 的新头寸，价值约为 4,572,000 美元。瑞银集团在第四季度将其在 Doximity 的持股增加了 26.5%。瑞银集团目前持有 680,260 股公司股票，价值 30,122,000 美元，在上个季度又增持了 142,408 股。Blair William &amp; Co. IL 在第三季度将其在 Doximity 的持股增加了 1,990.7%。Blair William &amp; Co. IL 目前持有 362,740 股公司股票，价值 26,534,000 美元，在上个季度又增持了 345,390 股。最后，William Blair Investment Management LLC 在第三季度将其在 Doximity 的持股增加了 11.7%。William Blair Investment Management LLC 目前持有 5,829,169 股公司股票，价值 426,404,000 美元，在上个季度又增持了 609,775 股。对冲基金和其他机构投资者持有公司股票的 87.19%。</p>
<h2>更多 Doximity 新闻</h2>
<p>以下是本周影响 Doximity 的主要新闻故事：</p>
<ul>
<li>积极情绪：Doximity 报告调整后每股收益为 0.26 美元，超过了较低的分析师预期 0.17 美元，收入同比增长 5.1%，达到 1.4537 亿美元，显示出业务仍在增长。Doximity 财报</li>
<li>积极情绪：管理层表示，人工智能工具的采用和大型客户的增长促进了参与度，公司强调了创纪录的自由现金流和持续的人工智能整合努力。Doximity 2026 财年第四季度财报电话会议要点</li>
<li>中性情绪：华尔街分析师通过下调目标价作出回应，但大多数保持中性至积极评级，表明该股票可能被视为超卖，而不是基本面破裂。分析师目标价更新</li>
<li>消极情绪：更大的担忧是，Doximity 2027 财年的收入指引为 6.64 亿至 6.76 亿美元，低于 6.96 亿美元的共识，指向比投资者预期更慢的增长前景。Doximity 2026 财年第四季度财报电话会议记录</li>
<li>消极情绪：2027 财年第一季度收入指引为 1.51 亿至 1.52 亿美元，也未达到预期，进一步加深了对增长放缓和与人工智能相关的投资对利润率施加压力的担忧。Doximity 因疲软的指引大幅下跌</li>
<li>消极情绪：额外的情绪压力来自于异常的看跌期权购买和披露的内部人士股票出售，这两者都可能在交易者中发出谨慎信号。内部交易披露</li>
</ul>
<h2>关于 Doximity</h2>
<p>(获取免费报告)</p>
<p>Doximity（股票代码：DOCS）运营一个数字专业网络和通信平台，主要为临床医生设计。公司总部位于旧金山，连接医生、护士执业者、医师助理和其他医疗专业人员，提供简化临床沟通、远程医疗交付和获取专业特定医疗信息的工具。其平台被定位为一个专业中心，临床医生可以在此管理工作流程、跟进医学新闻并与同行安全协作。</p>
<p>该公司的产品包括安全消息传递和视频远程医疗功能，使临床医生能够在保护患者信息的同时与患者和同事进行咨询。</p>
<h2>另见</h2>
<ul>
<li>五只我们更看好的股票，胜过 Doximity</li>
<li>YETI 在财报超预期和上调前景后反弹</li>
<li>三家领先量子公司的 Q1 财报对比</li>
<li>思科的垂直反弹可能仍处于早期阶段</li>
<li>亚马逊与阿里巴巴：现在显然更具价值的选择</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPURPQ1M?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="650" height="330" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPURPQ1M"/></p>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。如对本故事有任何问题或意见，请发送邮件至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在 Doximity 吗？</h2>
<p>在考虑 Doximity 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐的股票。MarketBeat 已识别出五只顶级分析师正在悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而 Doximity 并不在名单上。</p>
<p>虽然 Doximity 目前在分析师中获得中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>查看这五只股票</p>

摩根大通

DOCS

LGHT

HEAL

<p>摩根大通已将 Doximity（NYSE:DOCS）的目标股价从 33.00 美元下调至 28.00 美元，维持 “中性” 评级。这表明与前一交易日收盘价相比，仍有 60.38% 的上涨潜力。其他券商也调整了他们的目标价，罗伯特·W·贝尔德设定的目标为 18.00 美元，BMO 资本市场为 20.00 美元，美银为 47.00 美元。Doximity 的股票交易价格下跌至 17.46 美元，市值为 32.2 亿美元。内部人士最近出售了股份，显示出对该股票估值的潜在担忧</p>

<p>Doximity (NYSE:DOCS - Get Free Report) had its price objective decreased by research analysts at JPMorgan Chase &amp; Co. from $33.00 to $28.00 in a note issued to investors on Thursday,Benzinga reports. The firm currently has a &#34;neutral&#34; rating on the stock. JPMorgan Chase &amp; Co.'s price target would suggest a potential upside of 60.38% from the company's previous close.</p>
<div class="lb-trans"><p>Doximity（纽约证券交易所代码：DOCS - 获取免费报告）在周四发布给投资者的报告中，摩根大通将其目标价格从 33.00 美元下调至 28.00 美元。该公司目前对该股票的评级为 “中性”。摩根大通的目标价格暗示该公司股价有 60.38% 的潜在上涨空间。</p>
</div><ul>
<li>Doximity is the Facebook and LinkedIn of the Medical Community</li>
</ul>
<div class="lb-trans"><ul>
<li>Doximity 是医疗社区的 Facebook 和 LinkedIn</li>
</ul>
</div><p>Several other brokerages also recently commented on DOCS. Robert W. Baird reaffirmed a &#34;neutral&#34; rating and set a $18.00 target price (down from $40.00) on shares of Doximity in a report on Thursday. BMO Capital Markets reduced their target price on Doximity from $25.00 to $20.00 and set a &#34;market perform&#34; rating for the company in a report on Thursday. Bank of America reduced their price target on shares of Doximity from $56.00 to $47.00 and set a &#34;buy&#34; rating for the company in a research report on Thursday, April 16th. Needham &amp; Company LLC reduced their price target on shares of Doximity from $55.00 to $27.00 and set a &#34;buy&#34; rating for the company in a research report on Thursday. Finally, Jefferies Financial Group downgraded shares of Doximity from a &#34;buy&#34; rating to a &#34;hold&#34; rating and set a $19.00 price target for the company. in a research report on Thursday. Two analysts have rated the stock with a Strong Buy rating, eight have given a Buy rating and thirteen have assigned a Hold rating to the company's stock. According to data from MarketBeat.com, the stock currently has an average rating of &#34;Moderate Buy&#34; and a consensus target price of $31.48.</p>
<div class="lb-trans"><p>其他几家券商也最近对 DOCS 发表了评论。罗伯特·W·贝尔德在周四的报告中重申了 “中性” 评级，并将 Doximity 的目标价格设定为 18.00 美元（从 40.00 美元下调）。BMO 资本市场将 Doximity 的目标价格从 25.00 美元下调至 20.00 美元，并在周四的报告中对该公司给予 “市场表现” 评级。美国银行将 Doximity 的目标价格从 56.00 美元下调至 47.00 美元，并在 4 月 16 日的研究报告中对该公司给予 “买入” 评级。Needham &amp; Company LLC 将 Doximity 的目标价格从 55.00 美元下调至 27.00 美元，并在周四的研究报告中对该公司给予 “买入” 评级。最后，杰弗瑞金融集团将 Doximity 的评级从 “买入” 下调至 “持有”，并为该公司设定了 19.00 美元的目标价格。两位分析师对该股票给予了强烈买入评级，八位给予了买入评级，十三位对该公司的股票给予了持有评级。根据 MarketBeat.com 的数据，该股票目前的平均评级为 “适度买入”，共识目标价格为 31.48 美元。</p>
</div><p><strong>View Our Latest Stock Analysis on Doximity</strong></p>
<div class="lb-trans"><p><strong>查看我们对 Doximity 的最新股票分析</strong></p>
</div><h2>Doximity Stock Performance</h2>
<div class="lb-trans"><h2>Doximity 股票表现</h2>
</div><ul>
<li>Doximity is an Overlooked Medical Ecosystem AI Play</li>
</ul>
<div class="lb-trans"><ul>
<li>Doximity 是一个被忽视的医疗生态系统 AI 投资</li>
</ul>
</div><p>DOCS stock traded down $5.93 on Thursday, hitting $17.46. 17,685,978 shares of the company's stock traded hands, compared to its average volume of 3,604,347. Doximity has a 1-year low of $17.15 and a 1-year high of $76.51. The firm has a market cap of $3.22 billion, a PE ratio of 14.64, a price-to-earnings-growth ratio of 1.88 and a beta of 1.36. The stock's fifty day moving average is $24.27.</p>
<div class="lb-trans"><p>周四，DOCS 股票下跌 5.93 美元，跌至 17.46 美元。该公司共交易了 17,685,978 股股票，而其平均交易量为 3,604,347 股。Doximity 的 1 年最低价为 17.15 美元，1 年最高价为 76.51 美元。该公司的市值为 32.2 亿美元，市盈率为 14.64，市盈增长比率为 1.88，贝塔值为 1.36。该股票的 50 日移动平均线为 24.27 美元。</p>
</div><p>Doximity announced that its Board of Directors has initiated a stock repurchase program on Thursday, February 5th that allows the company to repurchase $500.00 million in shares. This repurchase authorization allows the company to purchase up to 8% of its shares through open market purchases. Shares repurchase programs are generally an indication that the company's management believes its shares are undervalued.</p>
<div class="lb-trans"><p>Doximity 宣布其董事会于 2 月 5 日启动了一项股票回购计划，允许公司回购 5 亿美元的股票。该回购授权允许公司通过公开市场购买最多 8% 的股份。股票回购计划通常表明公司的管理层认为其股票被低估。</p>
</div><h2>Insider Activity</h2>
<div class="lb-trans"><h2>内部活动</h2>
</div><ul>
<li>Doximity Stock is an Interesting Healthcare Play</li>
</ul>
<div class="lb-trans"><ul>
<li>Doximity 股票是一个有趣的医疗投资</li>
</ul>
</div><p>In other Doximity news, insider Siddharth Sitaram sold 2,309 shares of the stock in a transaction that occurred on Monday, May 11th. The shares were sold at an average price of $25.77, for a total value of $59,502.93. Following the completion of the sale, the insider owned 89,396 shares in the company, valued at $2,303,734.92. This represents a 2.52% decrease in their position. The transaction was disclosed in a filing with the Securities &amp; Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Kira Scherer Wampler sold 9,000 shares of the stock in a transaction that occurred on Thursday, May 7th. The stock was sold at an average price of $26.06, for a total transaction of $234,540.00. Following the completion of the sale, the director owned 19,839 shares of the company's stock, valued at approximately $517,004.34. The trade was a 31.21% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders sold 18,055 shares of company stock valued at $456,061. Company insiders own 31.30% of the company's stock.</p>
<div class="lb-trans"><p>在其他 Doximity 新闻中，内部人士 Siddharth Sitaram 在 5 月 11 日的交易中出售了 2,309 股股票，平均售价为 25.77 美元，总价值为 59,502.93 美元。出售完成后，该内部人士持有 89,396 股公司股票，价值约为 2,303,734.92 美元。这代表其持股减少了 2.52%。该交易在向证券交易委员会的备案中披露，相关信息可通过此链接获取。该交易是在预先安排的 10b5-1 交易计划下执行的。出售是为了覆盖与股权奖励归属相关的税收扣缴义务。此外，董事 Kira Scherer Wampler 在 5 月 7 日的交易中出售了 9,000 股股票，平均售价为 26.06 美元，总交易额为 234,540.00 美元。出售完成后，该董事持有 19,839 股公司股票，价值约为 517,004.34 美元。该交易使其持股减少了 31.21%。该出售的 SEC 备案提供了更多信息。该交易是在预先安排的 10b5-1 交易计划下执行的。在过去三个月中，内部人士出售了价值 456,061 美元的 18,055 股公司股票。公司内部人士持有公司股票的 31.30%。</p>
</div><h2>Institutional Investors Weigh In On Doximity</h2>
<div class="lb-trans"><h2>机构投资者对 Doximity 的看法</h2>
</div><p>A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Vanguard Group Inc. raised its stake in shares of Doximity by 4.1% in the 4th quarter. Vanguard Group Inc. now owns 13,285,485 shares of the company's stock valued at $588,281,000 after acquiring an additional 518,916 shares in the last quarter. Aubrey Capital Management Ltd bought a new position in shares of Doximity in the 3rd quarter valued at approximately $4,572,000. UBS Group AG raised its stake in shares of Doximity by 26.5% in the 4th quarter. UBS Group AG now owns 680,260 shares of the company's stock valued at $30,122,000 after acquiring an additional 142,408 shares in the last quarter. Blair William &amp; Co. IL raised its stake in shares of Doximity by 1,990.7% in the 3rd quarter. Blair William &amp; Co. IL now owns 362,740 shares of the company's stock valued at $26,534,000 after acquiring an additional 345,390 shares in the last quarter. Finally, William Blair Investment Management LLC raised its stake in shares of Doximity by 11.7% in the 3rd quarter. William Blair Investment Management LLC now owns 5,829,169 shares of the company's stock valued at $426,404,000 after acquiring an additional 609,775 shares in the last quarter. Hedge funds and other institutional investors own 87.19% of the company's stock.</p>
<div class="lb-trans"><p>一些对冲基金和其他机构投资者最近增加或减少了对该股票的持股。先锋集团在第四季度将其在 Doximity 的持股增加了 4.1%。先锋集团目前持有 13,285,485 股公司股票，价值 588,281,000 美元，在上个季度又增持了 518,916 股。Aubrey Capital Management Ltd 在第三季度购买了 Doximity 的新头寸，价值约为 4,572,000 美元。瑞银集团在第四季度将其在 Doximity 的持股增加了 26.5%。瑞银集团目前持有 680,260 股公司股票，价值 30,122,000 美元，在上个季度又增持了 142,408 股。Blair William &amp; Co. IL 在第三季度将其在 Doximity 的持股增加了 1,990.7%。Blair William &amp; Co. IL 目前持有 362,740 股公司股票，价值 26,534,000 美元，在上个季度又增持了 345,390 股。最后，William Blair Investment Management LLC 在第三季度将其在 Doximity 的持股增加了 11.7%。William Blair Investment Management LLC 目前持有 5,829,169 股公司股票，价值 426,404,000 美元，在上个季度又增持了 609,775 股。对冲基金和其他机构投资者持有公司股票的 87.19%。</p>
</div><h2>More Doximity News</h2>
<div class="lb-trans"><h2>更多 Doximity 新闻</h2>
</div><p>Here are the key news stories impacting Doximity this week:</p>
<div class="lb-trans"><p>以下是本周影响 Doximity 的主要新闻故事：</p>
</div><ul>
<li>Positive Sentiment: Doximity reported adjusted EPS of $0.26, which topped a lower analyst estimate of $0.17, and revenue rose 5.1% year over year to $145.37 million, showing the business is still growing. Doximity Earnings Report</li>
<li>Positive Sentiment: Management said AI tool adoption and growth in larger customers helped engagement, and the company highlighted record free cash flow and continued AI integration efforts. Doximity Q4 2026 Earnings Call Highlights</li>
<li>Neutral Sentiment: Wall Street analysts responded by cutting price targets, but most kept neutral-to-positive ratings, suggesting the stock may be viewed as oversold rather than fundamentally broken. Analyst Price Target Updates</li>
<li>Negative Sentiment: The bigger concern is that Doximity’s fiscal 2027 revenue guidance of $664 million to $676 million came in below the $696 million consensus, pointing to a slower growth outlook than investors wanted. Doximity Q4 2026 Earnings Call Transcript</li>
<li>Negative Sentiment: First-quarter fiscal 2027 revenue guidance of $151 million to $152 million also missed expectations, reinforcing worries that growth is slowing and AI-related investment is pressuring margins. Doximity plunges on weak guidance</li>
<li>Negative Sentiment: Additional sentiment pressure came from unusual put buying and a disclosed insider share sale, both of which can signal caution among traders. Insider Trade Disclosure</li>
</ul>
<div class="lb-trans"><ul>
<li>积极情绪：Doximity 报告调整后每股收益为 0.26 美元，超过了较低的分析师预期 0.17 美元，收入同比增长 5.1%，达到 1.4537 亿美元，显示出业务仍在增长。Doximity 财报</li>
<li>积极情绪：管理层表示，人工智能工具的采用和大型客户的增长促进了参与度，公司强调了创纪录的自由现金流和持续的人工智能整合努力。Doximity 2026 财年第四季度财报电话会议要点</li>
<li>中性情绪：华尔街分析师通过下调目标价作出回应，但大多数保持中性至积极评级，表明该股票可能被视为超卖，而不是基本面破裂。分析师目标价更新</li>
<li>消极情绪：更大的担忧是，Doximity 2027 财年的收入指引为 6.64 亿至 6.76 亿美元，低于 6.96 亿美元的共识，指向比投资者预期更慢的增长前景。Doximity 2026 财年第四季度财报电话会议记录</li>
<li>消极情绪：2027 财年第一季度收入指引为 1.51 亿至 1.52 亿美元，也未达到预期，进一步加深了对增长放缓和与人工智能相关的投资对利润率施加压力的担忧。Doximity 因疲软的指引大幅下跌</li>
<li>消极情绪：额外的情绪压力来自于异常的看跌期权购买和披露的内部人士股票出售，这两者都可能在交易者中发出谨慎信号。内部交易披露</li>
</ul>
</div><h2>About Doximity</h2>
<div class="lb-trans"><h2>关于 Doximity</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>(获取免费报告)</p>
</div><p>Doximity, trading as DOCS, operates a digital professional network and communications platform designed primarily for clinicians. Headquartered in San Francisco, the company connects physicians, nurse practitioners, physician assistants and other healthcare professionals, providing tools that streamline clinical communication, telehealth delivery and access to specialty-specific medical information. Its platform is positioned as a professional hub where clinicians manage their workflows, stay current with medical news and collaborate securely with peers.</p>
<div class="lb-trans"><p>Doximity（股票代码：DOCS）运营一个数字专业网络和通信平台，主要为临床医生设计。公司总部位于旧金山，连接医生、护士执业者、医师助理和其他医疗专业人员，提供简化临床沟通、远程医疗交付和获取专业特定医疗信息的工具。其平台被定位为一个专业中心，临床医生可以在此管理工作流程、跟进医学新闻并与同行安全协作。</p>
</div><p>The company’s offerings include secure messaging and video telehealth capabilities that enable clinicians to consult with patients and colleagues while protecting patient information.</p>
<div class="lb-trans"><p>该公司的产品包括安全消息传递和视频远程医疗功能，使临床医生能够在保护患者信息的同时与患者和同事进行咨询。</p>
</div><h2>See Also</h2>
<div class="lb-trans"><h2>另见</h2>
</div><ul>
<li>Five stocks we like better than Doximity</li>
<li>YETI Rallies After Earnings Beat and Raised Outlook</li>
<li>How the 3 Leading Quantum Firms Stack Up After Q1 Earnings</li>
<li>Cisco’s Vertical Rally May Still Be in the Early Innings</li>
<li>Amazon vs. Alibaba: One Is Clearly The Better Value Play right Now</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票，胜过 Doximity</li>
<li>YETI 在财报超预期和上调前景后反弹</li>
<li>三家领先量子公司的 Q1 财报对比</li>
<li>思科的垂直反弹可能仍处于早期阶段</li>
<li>亚马逊与阿里巴巴：现在显然更具价值的选择</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPURPQ1M" alt="" original-src="https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx?Prefix=NYSE&amp;Symbol=DOCS"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。如对本故事有任何问题或意见，请发送邮件至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Doximity Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 Doximity 吗？</h2>
</div><p>Before you consider Doximity, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 Doximity 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Doximity wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐的股票。MarketBeat 已识别出五只顶级分析师正在悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而 Doximity 并不在名单上。</p>
</div><p>While Doximity currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Doximity 目前在分析师中获得中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>查看这五只股票</p>
</div>

JPMorgan Chase & Co. Lowers Doximity (NYSE:DOCS) Price Target to $28.00

Market Beat

Doximity

Langar Global HealthTech ETF

First Trust Nasdaq Lux Digital Health Solutions ETF

Global X HealthTech ETF

Defiance Daily Target 2X Long JPM ETF

摩根大通将 Doximity（纽约证券交易所代码:DOCS）的目标股价下调至 28.00 美元